SARS-CoV-2/influenza A/influenza B

ʻO ka wehewehe pōkole:

He kūpono kēia kit no ka ʻike in vitro qualitative o SARS-CoV-2, influenza A a me ka influenza B nucleic acid o ka nasopharyngeal swab a me nā oropharyngeal swab samples o ka poʻe i manaʻo ʻia i ka maʻi o SARS-CoV-2, influenza A a me ka influenza. B. Hiki ke hoʻohana ʻia i ka maʻi pneumonia a me nā hihia puʻupuʻu i manaʻo ʻia a no ka ʻike qualitative a me ka ʻike ʻana i ka SARS-CoV-2, influenza A a me ka influenza B nucleic acid i loko o ka nasopharyngeal swab a me nā oropharyngeal swab samples o ka maʻi coronavirus novel ma nā kūlana ʻē aʻe.

E hoʻouna i ka leka uila iā mākou

Huahana Huahana

Inoa mea kūʻai

HWTS-RT148-SARS-CoV-2/influenza A /influenza B Nucleic Acid Combined Detection Kit (Fluorescence PCR)

Kanal

Inoa Channel	PCR-Mix 1	PCR-Mix 2
Kanal FAM	gene ORF1ab	IVA
Kaila VIC/HEX	Ka hooponopono kuloko	Ka hooponopono kuloko
CY5 Channel	N gene	/
Kanal ROX	E gene	IVB

Nā ʻāpana ʻenehana

Waihona	-18 ℃
Kau-ola	12 mahina
ʻAno Hoʻohālike	nasopharyngeal swabs and oropharyngeal swabs
Kuhikuhi	ʻO SARS-CoV-2 ʻekolu mau pahuhopu (Orf1ab, N a me E genes)/influenza A / influenza B
Ct	≤38
CV	≤10.0%
LoD	SARS-CoV-2:300 Kope/mL influenza A virus:500 Kope/mL influenza B:500 kope/mL
kikoo	a) Ua hōʻike ʻia nā hopena hoʻāʻo keʻa ua kūpono ka pahu me ka coronavirus kanaka SARSr- CoV, MERSr-CoV, HcoV-OC43, HcoV-229E, HcoV-HKU1, HCoV-NL63, respiratory syncytial virus A a me B, parainfluenza virus 1, 2 a me 3, rhinovirusA, B a me C, adenovirus 1, 2, 3, 4, 5, 7 a me 55, metapneumovirus kanaka, enterovirus A, B, C a me D, virus cytoplasmic pulmonary kanaka, virus EB, measles virus Human cytomegalovirus, rotavirus, norovirus, mumps virus, varicella zoster virus, Mycoplasma pneumoniae, Chlamydia pneumoniae, Legionella, pertussis, Haemophilus influenzae, Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, Klebsiella pneumoniae, Mycobacterium tuberculosis, There was candida glatus, Candidallus fuss. ka hopena kea ma waena o Pneumocystis yersini a me Cryptococcus neoformans. b) Hiki ke hoʻopilikia: koho i ka mucin (60mg / mL), 10% (V / V) koko kanaka, diphenylephrine (2mg / mL), hydroxymethylzoline (2mg / mL), sodium chloride (loaʻa ka preservative) (20mg / mL), beclomethasone (20mg/mL), dexamethasone (20mg/mL), flunisone (20μg/mL), triamcinolone acetonide (2mg/mL), budesonide (2mg/mL), mometasone (2mg/mL), fluticasone (2mg/mL), histamine hydrochloride (5mg/mL), α-Interferon (800IU/mL), zanamivir (20mg/mL), ribavirin (10mg/mL), oseltamivir (60ng/mL), pramivir (1mg/mL), lopinavir (500mg/mL). ), ritonavir (60mg/mL), mupirocin (20mg/mL), azithromycin (1mg/mL), ceprotene (40μg/mL) Meropenem (200mg/mL), levofloxacin (10μg/mL) a me tobramycin (0.6mg/mL) .Ua hōʻike ʻia nā hopena ʻaʻole i loaʻa i nā mea keakea i nā ʻano i luna aʻe ka pane keakea i nā hopena ʻike o nā pathogens.
Nā mea hana pili	Hoʻohana ʻia Biosystems 7500 Pūnaehana PCR manawa maoli Hoʻohana ʻia ʻo Biosystems 7500 Fast Real-Time PCR Systems SLAN^®-96P Pūnaehana PCR Manawa maoli QuantStudio™ 5 Pūnaehana PCR Manawa maoli LightCycler^®480 Pūnaehana PCR manawa maoli LineGene 9600 Plus Pūnaehana ʻike PCR manawa maoli MA-6000 ʻOiaʻiʻo ka nui o ka wela wela BioRad CFX96 Pūnaehana PCR Manawa maoli BioRad CFX Opus 96 Pūnaehana PCR Manawa maoli